Lead, Oncology HTA & Modelling Science

Astrazeneca Plc; Laza; Presencial; EUR 90.000 - 135.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Office in Barcelona

Diversity and inclusion

Descripción de la vacante

AstraZeneca is seeking a Health Econ/HTA Modelling Scientist to develop and communicate patient and economic value for HTA submissions across global markets. You will work with cross-functional partners to translate evidence into economic value to improve patient access.

The role offers involvement in innovative methods, with a focus on oncology and HTA strategy within a collaborative HMS team in a dynamic environment.

Formación

• Bachelor's or post-graduate degree in economics, health economics, statistics/biostatistics, mathematics or equivalent quantitative degree with a statistical component.
• Minimum 5 years in consultancy or industry applying modelling for HTA submissions.
• Expert knowledge in economic modelling and budget impact analysis with hands-on Excel modelling.

Responsabilidades

• Contribute to strategic approach and delivery of health economic models for HTA submissions globally.
• Act as primary point of contact for HE deliverables guidance and support.
• Apply novel modelling methodologies, including surrogacy and survival analyses.
• Support wider cross-functional decision-making beyond HTA and market access.
• Provide leadership and input for HMS tools, guidance, and external publications.
• Ensure quality assurance of modelling work and manage external vendors.

Conocimientos

Health economics

HTA submissions

Economic modelling

Budget impact

Excel modelling

R/SAS

Communication skills

Cross-functional

Indirect comparisons

GenAI for HTA

Educación

Bachelor's or postgraduate in economics/biostatistics

Herramientas

R

SAS

Excel

Descripción del empleo

AstraZeneca is seeking a Health Econ/HTA Modelling Scientist to develop and communicate patient and economic value for HTA submissions across global markets. You will work with cross-functional partners to translate evidence into economic value to improve patient access.

The role offers involvement in innovative methods, with a focus on oncology and HTA strategy within a collaborative HMS team in a dynamic environment.